Healthcare

Adherium released its quarterly activities report on 30 October 2026. Remote patient monitoring subscription accrual revenue was $539k, up 12.5% from A$479k in Q4 FY26. The company described this as the fifth consecutive quarter of record RPM revenue.

The agreement values UNP at up to approximately $1.15 billion, combining an upfront payment with later milestone-based amounts. argenx will pay $550 million in cash on hand at closing. The remaining consideration of up to $595 million depends on the achievement of specified development …

AVITA Medical reported third quarter 2026 results on 5 November 2026. Total revenue rose 53% year on year and 20% sequentially to $26.1 million, driven by RECELL and increasing use of Cohealyx.

Neuren reported on 5 November 2026 that Q3 2026 DAYBUE net sales were US$140 million, up 39% on Q3 2025, driven by uptake of DAYBUE STIX.

Patrys released its quarterly activities report on 29 October 2026. The company said human research ethics approval was secured and first participants were dosed in the RLS-2202 Phase 1a trial at CMAX.

On 27 October 2026, Argent announced a 10-year exclusive worldwide licensing agreement with Thai Phytomed International Co., Ltd. for the commercial development of four proprietary cannabis genotypes.

On 6 November 2026, Pacific Edge announced that the final Local Coverage Determination for urine-based biomarkers in microhematuria patients had been published, confirming Medicare coverage for Cxbladder Triage and Triage Plus from 20 December 2026. The company estimated about 1.14 million testing opportunities a …